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Antimicrobial resistance (AMR) is emerging 
and is a threat for human and animal health. This 
increasing resistance results into treatment 
failures and increased mortality in humans and 
animals. If there is no action to reduce 
antimicrobial use (AMU), it is forecasted that the 
number of people dying due to AMR will increase 
considerably in the near future. AMU in animals 
poses a potential risk for public health as it 
contributes to the selection and spread of AMR 
which can disseminate to humans. Therefore, at 
global level WHO, FAO and OIE combined efforts in 
a such called One Health approach to minimize the 
public health impact of AMR associated with AMU 
in farm animals. The Global Action Plan on 
antimicrobial resistance (GAP) has been adopted 
by the World Health Assembly in 2015. This plan 
contains five strategic objectives. WHO urged all 
member states to develop a National Action Plan in 
line with the five objectives of the GAP, and with a 
One Health approach. Indonesia has submitted the 
National Action Plan on Antimicrobial Resistance 
2017-2019 in the Library of National Action Plans 
of WHO. 
Although it is not clear to what level AMU in 
animal production contributes to the AMR problem 
humans, there is a worldwide urge to reduce AMU 
in animal production to a minimum to protect 
human health. The basis of this so-called 
‘antimicrobial stewardship’ is focusing on 
(preventive) measures which enable animals to 
remain healthy and thus take away the need for 
antimicrobial treatment. Another pillar of 
stewardship is limiting and strictly regulating the 
use of so-called ‘’critically important 
antimicrobials for human medicine’’, like 
fluoroquinolones. It can be difficult to change AMU 
practices which have become habits for farmers 
and veterinarians; therefore specific triggers are 
required. In the Netherlands the total therapeutic 
AMU (in mass sold) in farm animals doubled 
between 1990 and 2007; parallel to the EU-ban of 
antimicrobial growth promotors which were 
completely phased out by 2006. From 2005 
onwards, several events triggered a series of 
measures and initiatives to reduce AMU in 
livestock with almost 70%. This reduction was 
followed by reduced AMR levels in livestock. Some 
key success factors were: clear reduction targets 
defined by the government, having full 
transparency on antimicrobial prescription and 
usage, the existence of a surveillance system for 
AMR, and a close collaboration of all stakeholders 
and a shared goal. Although specific contexts differ 
between countries and production systems, 
tailored approaches taking into account specific 
contexts and stakeholders can be effective in 
responsible use of antimicrobials. 
